Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 25, 2017
Pharmacy Choice - Pharmaceutical News - Acceleron Announces Clinical Presentations on Luspatercept at the 22nd Congress of the European Hematology Association [Syrian Arab News Agency] - May 25, 2017

Pharmacy News Article

 5/19/17 - Acceleron Announces Clinical Presentations on Luspatercept at the 22nd Congress of the European Hematology Association [Syrian Arab News Agency]

Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to treat serious and rare diseases, today announced that two abstracts on luspatercept will be presented at the 22nd Congress of the European Hematology Association (EHA) in Madrid, Spain on June 22-25, 2017. Luspatercept is being developed as part of the global collaboration between Acceleron and Celgene.

The oral and poster presentations will include efficacy, duration of response, and long-term safety results from the ongoing Phase 2 studies with luspatercept in myelodysplastic syndromes (MDS) and beta-thalassemia. The presentations at the conference will include updated information beyond that included in the abstracts available online on the EHA conference website. The beta-thalassemia presentation will review results updated from the ASH 2016 presentation in December and the MDS presentation will highlight results updated from the recent International Symposium on MDS earlier this month.

Oral presentation

Title: Luspatercept Increases Hemoglobin and Decreases Transfusion Burden in Adults with Beta-Thalassemia (Abstract: S129)

Session: Thalassemia

Date: Friday, June 23rd

Time: 11:45 a.m. CEST (IFEMA, Room N105)

Poster presentation

Title: Luspatercept Increases Hemoglobin and Reduces Transfusion Burden in Patients with

Lower-Risk Myelodysplastic Syndromes (MDS): Long-Term Results from Phase 2 PACE-MDS Study (Abstract: P666)

Session: Myelodysplastic Syndromes Clinical 2

Date: Saturday, June 24th

Time: 5:30 - 7:00 p.m. CEST (IFEMA, Poster Area, Hall 7)

The luspatercept clinical poster and slides from the oral presentation will be available immediately following the presentations at the conference in the Science section on Accelerons website, www.acceleronpharma.com.



(c) International 2006-2017, SANA Provided by SyndiGate Media Inc. (Syndigate.info).

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
May 25: Acne Vulgaris: Comprehensive Pharmaceutical Care
Last Chance
May 26: Dispensing Controlled Substances in Today’s Pharmacy
May 30: The American Geriatric Society Beers Criteria: Implications for Pharmacy Practice
May 31: Medication Safety & Drug Safety Alerts
Jun 01: Adult Immunizations: A Guide for Pharmacists, Techs & NPs
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415